Larvol Delta - Therapeutic-horizons-in-targeting-XPO1-with-small-inhibitor-molecules-Recent-achievements-synthetic-strategies-opportunities-challenges-and-future-perspectives

eltanexor (KPT-8602) - Karyopharm

verdinexor (KPT-335) - Anivive, Antengene

Xpovio (selinexor) - Karyopharm

http://www.ncbi.nlm.nih.gov/pubmed/41330116

Hamada S Abulkhair

Dec 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next